Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Donor Alliance Announces Paul Lange as Medical Director


Dr. Paul Lange, M.D., F.C.C.P., has been named medical director at Donor Alliance, the federally designated organ procurement organization serving Colorado and most of Wyoming. A board certified physician in pulmonary and critical care medicine, Lange will assume the medical director role on January 25, 2021.

Dr. Lange brings nearly three decades of clinical experience to the role as well as extensive involvement in graduate and undergraduate medical education. He has served in various leadership roles, including chief medical officer at Gift of Life Michigan, the organ procurement organization for the state of Michigan, and chief medical officer for Ascension Borgess Medical Group. Most recently, he was an internist at Greeley-based Northern Colorado Medical Center.

“Dr. Lange is a highly respected clinical leader with extensive experience guiding critical care operations,” said Jennifer Prinz, president and CEO of Donor Alliance. “His passion for saving lives through donation and transplantation and his focus on quality supports our long-term commitment to performance improvement and will lead to more lives saved.”

As medical director, Dr. Lange will be responsible for providing clinical guidance and oversight of the organization’s clinical practices, medical policies and processes.

Dr. Lange is a member of numerous scientific and professional organizations, including the Society of Critical Care Medicine (SCCM), American College of Chest Physicians (ACCP), American Thoracic Society (ATS) and American College of Physicians (ACP). A graduate of the University of Michigan with a BS in Biology/Psychology, he earned his MD at Michigan State University College of Human Medicine in 1989.

About Donor Alliance

Donor Alliance is a non-profit organization dedicated to saving lives through organ and tissue donation and transplantation. As the organ and tissue procurement agency for Colorado and most of Wyoming, Donor Alliance serves more than 5.8 million residents and more than 100 hospitals. Donor Alliance adheres to the highest medical, regulatory and ethical standards, and meets every performance standard. By respectfully working with the families of organ and tissue donors, maintaining partnerships with hospitals, educating residents on the life-saving benefits of donation and inspiring them to sign up on the state’s donor registry, Donor Alliance is able to save lives through organ and tissue donation and transplantation. Colorado and Wyoming boast some of the highest rates of donor registration in the country, which directly translates to more lives saved and healed through organ and tissue transplantation. Donor Alliance is one of 58 federally designated organizations of its kind in the United States. For more information visit DonorAlliance.org or the Donate Life Colorado or Donate Life Wyoming Facebook pages.

Share article on social media or email:

Sales of Shark Tank Winning Immune Support Product EZC Pak Soar Amid COVID-19 Outbreak


EZC Pak 5-Day Immune Support Pack Carton

EZC Pak Immune Support Sales Surge 300% Amid COVID-19 Outbreak

We have an uphill battle against superbugs, but we’re not done fighting.

E-Z-C Pak, the first physician formulated immune support pack composed of Echinacea, Zinc, and Vitamin C designed to reduce antibiotic overuse in cold and flu has surged in demand amid the COVID-19 outbreak. Company spokesperson Julianne Jahn reported that brand sales are up over 850% online and over 300% overall from the previous fiscal year. The company’s Vitamin D product EZC Pak+D, launched last year, has become a top online seller, bolstered by research showing COVID-19 positive patients are four times less likely to require admission to intensive care units (ICUs) if they have normal levels of Vitamin D.

EZC Pak has won six awards over the past three years and was featured in a deal-winning over-the-top episode in Season 11 of structured reality television series Shark Tank.

“The COVID-19 pandemic has been one of the saddest periods of American history. The outbreak has exposed fundamental structural problems with the design of the US healthcare system. The inadequacies of our healthcare system across the management of infectious diseases and public health outbreaks, to psychiatric care, to the medical education system, to the coordination between public health agencies, to the dissemination of accurate health information to the American public has been on full display,” said CEO Sarath Malepati, MD.

“Antibiotics still don’t treat viruses. Yet antibiotic abuse has been extremely high this year. Superbugs are going to continue to be a problem both in healthcare facilities and the community for as long as bad medicine and bad healthcare continues to be our chosen path. These are complex problems that require humility, collaboration, and a long term outlook to solve. We have yet to reach that point,” Malepati said.

Dr. Malepati stated that funds from EZC Pak’s most successful year of sales to date will be allocated to ongoing support for antibiotic stewardship initiatives in community clinics in medically under-resourced areas of the US, international expansion, and building out the company’s clinical research program. “We have an uphill battle against superbugs, but we’re not done fighting,” he said.

About EZC Pak:

EZC Pak is the first physician formulated Immune Support Pack composed of certified organic Echinacea, Zinc, and Vitamin C designed to reduce the problem of antibiotic overuse in colds and flu. For more information on where to buy EZC Pak in your neighborhood, please visit the store locator at ezcpak.com.

Share article on social media or email:

Help.org Names the Best Drug and Alcohol Rehab Centers in Riverside


News Image

Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Riverside, CA for 2021. The informational guide recognizes the top 15 rehab facilities based on cost, treatment options, location, accompanying services, and more.

According to recent studies, drug overdose is the leading cause of death among people under age 50. In Riverside, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Riverside with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.

The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Riverside. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Riverside, CA please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-riverside-ca

2021 Best Rehab Facilities in Riverside, CA (in alphabetical order)

10 Acre Ranch Alcohol and Drug Treatment Facility

4175 Brockton Avenue

Riverside CA, 92501

877-228-4679

Adelante Recovery Center

49 Montecito Drive

Corona Del Mar, CA 92625

888-403-9027

Daylight Recovery Addiction Treatment Center

9480 Pats Point Drive

Corona, CA 92883

855-279-0254

Everlast-Recovery Center

6560 Sandy Lane

Riverside, CA 92505

833-940-1411

Full Circle Recovery

1860 Lampton Lane

Norco, CA 92860

951-737-6199

Hathaway Recovery

1042 East Belmont Abbey Lane

Claremont, CA 91711

909-971-3333

Inland Valley Recovery Services

934 N. Mountain Avenue

Suite A&B, Upland CA 91768

909-949-4667

Loma Linda University Health

11234 Anderson Street

Loma Linda, CA 92354

909-473-4492

MFI Recovery Center

5870 Arlington Avenue

Riverside, CA 92504

866-218-4697

Promising Outlook

4136 10th Street

Riverside, CA 92501

951-783-2487

Ranch Creek Recovery

25650 Bass Point

Murrieta, CA 92562

877-959-1855

Riverside Drug Treatment and Rehab Centers

11801 Pierce Street

St 200, Riverside, CA, 92505

951-221-4018

Riverside Recovery Resources

3757 Elizabeth Street

Riverside, CA 92506

951-684-3744

Sunrise Recovery Ranch

6690 Limonite Frontage Road

Riverside, CA 92509

844-255-9437

Whiteside Manor Drug & Alcohol Rehab Center

2743 Orange Street

Riverside, CA 92501

800-300-7326

ABOUT HELP.ORG

Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org’s team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.

Share article on social media or email:

Help.org Names the Best Drug and Alcohol Rehab Centers in Salem


News Image

Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Salem, OR for 2021. The informational guide recognizes the top 9 rehab facilities based on cost, treatment options, location, accompanying services, and more.

According to recent studies, drug overdose is the leading cause of death among people under age 50. In Salem, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Salem with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.

The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Salem. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Salem, OR please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-salem-or

2021 Best Rehab Facilities in Salem, OR (in alphabetical order)

Better Services Rehab Program

3760 Market Street NE Suite 506

Salem, OR 97301

503-689-8362

Bridgeway Recovery Services

3325 Harold Drive NE

Salem, OR 97305

503-363-2021

Clear Paths

3793 River Road N

Keizer, OR 97303

503-304-7002

De Paul Treatment Centers

1312 SW Washington Street

Portland, OR 97205

503-535-1151

Marion County, Oregon

2045 Silverton Road NE

Salem, OR 97301

503-576-4660

Oregon Recovery

465 Commercial Street NE Suite 150

Salem, OR 97301

503-362-2780

Pacific Ridge

1587 Pacific Ridge Lane SE

Jefferson, OR 97352

503-558-4499

Serenity Lane Treatment Center

960 Liberty Street Southeast

Salem, OR 97302

503-588-2804

Willamette Valley Comprehensive Treatment Center

1160 Liberty Street SE

Salem, OR 97302

844-559-1660

ABOUT HELP.ORG

Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org’s team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.

Share article on social media or email:

Azalea Ranked #408 Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500™


News Image

It’s an honor to be included in Deloitte’s 2020 Technology Fast 500 list this year. We’re proud to see the significant impact Azalea’s EHR and telehealth services has on our customers.

Azalea Health, a leading provider of cloud-based patient management and health IT solutions, today announced it ranked #408 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America now in its 26th year. Azalea Health grew 230% during this period.

Azalea Health’s Chief Executive Officer, Baha Zeidan, credits the company’s 230% revenue growth to Azalea’s flexible, cloud-based EHR and modern telehealth services. He said, “It’s an honor to be included in Deloitte’s 2020 Technology Fast 500 list this year. We’re proud to see the significant impact Azalea’s EHR and telehealth services has on our customers. It’s critical for today’s hospitals and care providers to have a flexible, cloud-based EHR — especially as our country’s health system prepares for new surges in patient demand and evolving needs to further combat this pandemic.”

Overall, 2020 Technology Fast 500™ companies achieved revenue growth ranging from 175% to 106,508% from 2016 to 2019, with median growth of 450%.

About Deloitte’s 2020 Technology Fast 500™:

Now in its 26th year, Deloitte’s Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $US50,000, and current-year operating revenues of at least $US5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

About Azalea Health:

Azalea Health (Azalea) is changing the way health IT platforms connect community-based healthcare providers and patients across the care continuum. Offering a 100% cloud-based, interoperable solution, Azalea delivers electronic health records, revenue cycle management, and a fully integrated telehealth solution designed for rural, community and urban practices and hospitals, especially those focused on underserved populations. Quick to deploy and intuitive to use, Azalea solutions ensure better care coordination and communication, and the “one patient, one record” approach provides care teams the agility to achieve better outcomes. The Azalea platform also delivers tools and resources to help providers meet their Meaningful Use requirements, and informs their strategies to navigate accountable care and alternative payment models.

About Deloitte:

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see http://www.deloitte.com/about to learn more about our global network of member firms.

Azalea PR Contact:

Lexi Herosian

lexi@scratchmm.com

Share article on social media or email:

Rural areas “hit hard” by surging coronavirus, rural health CEO in Indiana urges personal action


COVID-19 hit hard in rural areas this fall and is straining our rural hospitals – this represents an alarming trend and residents in rural towns need to quickly step up.

New COVID-19 cases in rural and small city areas of Indiana now generally outpace urban areas, with rural hospitals nearing capacity, according to reports of Hoosier rural hospital CEOs. “COVID-19 hit hard in rural areas this fall and is straining our rural hospitals and acute care facilities,” said Cara Veale, chief executive officer of the Indiana Rural Health Association (IRHA). “This represents an alarming trend and our Hoosier residents in rural towns need to quickly step up personal prevention and safety efforts.”

As of Nov. 24, the Indiana State Department of Health (https://www.coronavirus.in.gov/) reported 306,538 confirmed cases of COVID-19, adding an additional 5,702 cases to the state’s total. The agency also reported 103 new COVID-19 deaths, raising the mortality level to 5,169.

The national Rural Policy Research Institute (RUPRI) (https://rupri.public-health.uiowa.edu/publications/policybriefs/2020/COVID%20Longitudinal%20Data.pdf) warns that COVID-19 cases and death rates in rural areas of the United States have outstripped urban areas since the late summer. “As the Indiana State Department of Health has documented, the case numbers in rural areas are going in the wrong direction,” said Veale. “They’re soaring above new cases in urban areas, and hospital administrators tell me and the IRHA staff that rural hospitals and clinics reflect that worrisome fact on a statewide basis.”

Both rural and urban hospitals now face near-capacity levels as the state enters the Thanksgiving holiday season. The trend is worsened by medical staff storages, as hundreds of medical professionals have contracted the virus or are sheltering after direct exposure.

Indiana Gov. Eric Holcomb earlier urged Hoosiers to renew their efforts to take preventive measures. “We must do all we can to protect our hospital capacity,” the Governor said in a press briefing earlier this month.

Veale, who holds a Fellowship in the American College of Healthcare Executives (FACHE), warns that her colleagues at rural hospitals across Indiana are “gravely concerned” about the neglect of rural residents not taking appropriate steps to protect themselves or others.

“This unfortunate neglect helps drive the current surge, where numerous counties in Indiana recently turned red with multiple jumps in coronavirus cases,” continued Veale. “The plain and harsh fact is that if people – rural and urban alike – don’t mask up, don’t socially distance and assemble in unprotected groups, they increase their personal risks of infection, which we’re seeing lead to potential severe cases, even death.”

People living in rural areas tend to reflect health-related issues that heighten their risk if they are exposed to and come down with the coronavirus. More rural residents smoke, have cardiac and respiratory issues, are overweight and diabetic than their counterparts in Indiana urban areas, which makes them more at risk of hospitalization or severe symptoms.

“The independent nature of many living in rural areas tends to intensify some of these risks,” said Veale, who previously was a hospital executive at Daviess Community Hospital in Washington, a rural city in southwest Indiana. “People in rural areas like their independent lifestyles and many live multiple miles away from hospitals, clinics or physician offices, which can lead to neglecting important health care needs.”

Many counties are also medically underserved in Indiana, and thousands of rural Hoosiers don’t have healthcare insurance, which also contributes to unhealthy lifestyles.

“I’ve lived in rural areas for many years and I know people like this – they’re good people,” said Veale. “But many rural people in this current pandemic don’t like wearing masks and may not fully appreciate the risks they face or contribute to by not observing safety measures.”

The IRHA CEO joins rural hospital CEOs and medical professionals across Indiana in urgently encouraging all residents, and especially rural residents, to mask up, socially distance and forego the assembling together in large groups, whether friends or family.

“We in the medical profession understand the wearisome toll this pandemic year has taken on all of us,” Veale said. “This holiday season let us use common sense – let’s understand that taking safety precautions doesn’t take away our freedoms, it preserves our freedoms as we all take steps to end this pandemic.”

#     #     #

About the Indiana Rural Health Association

The Indiana Rural Health Association was organized in 1997 and is a nonprofit organization working to enhance the health and well-being of rural populations in Indiana through leadership, education, advocacy, collaboration, and resource development. The strength of the organization is through the present diverse membership and the founding organizers who are committed to impacting the health of citizens through the identification of rural health issues and through advocacy roles in both the public and private sectors. IRHA membership is made up of 3,300 diverse individuals and organizations, making it the largest state rural health association in the nation, and a nationally recognized leader in rural health care. For more information, visit http://www.indianaruralhealth.org.

Share article on social media or email:

We Mourn Together Announces Director of Donor Relations Joe Winters


We Mourn Together So No One Has To Mourn Alone

We Mourn Together

So No One Has To Mourn Alone

A charity effort launched on March 25, 2020, We Mourn Together creates space for virtual connectedness to community. “We are excited that Joe Winters has joined our project,” said Dan Baynes, COO of Frog Pond Productions, the 501(c)(3) tax-exempt charity established in 1999 as an educational communications network. “Joe brings professional experience and genuine enthusiasm to our pilot-phase of development. As Director of Donor Relations, Joe embodies our collective commitment to building our business to help lots of people.”

“We Mourn Together is specifically seeking to highlight the immediate need to recognize and designate Bedside Attendance as essential, thereby opening the doors of hospitals, CCRCs, hospice and homes to essential workers (secular and nonsecular) to go to the bedside and assume the duties of sitting vigil with ill and dying people,” said Joe Winters, who joined We Mourn Together in October. “It is time to acknowledge the desperate need for front line workers to step up to the bedside attendance of standing by and providing comfort care to the critically ill and dying.”

Joe goes on to say, “Bedside Attendance is essential in order to provide Comfort Care for critically Ill patients and at the end of life. Medicine and medical directives refer to “Comfort Care” and it is time now to designate as frontline essential workers those who stand by the bedside in order to comfort the ill and dying. We Mourn Together wishes to spotlight the immediate need of putting people and technology together to create space for virtual connectedness to family and friends at the end of life.”

We Share Together Meetings were launched in April, and are held weekly on Tuesday, Thursday, Friday and Saturday. Dan said, “We Mourn Together is seeking funding for our You Don’t Have to Be Alone Hotline, and Gather to Remember Dedicated Time to Mourn and our Virtual Memorial Vault are ways to create space for virtual connectedness to remember our lost loved ones.” Joe said, “As a project of Frog Pond Productions, all donations made to We Mourn Together are tax-deductible. We are actively seeking charitable contributions. Working together we can help many people in these challenging new times.”

We Mourn Together creates space for virtual connectedness to community. We Mourn Together is a program of Frog Pond Productions.

Frog Pond Productions

Doylestown PA

Share article on social media or email:

First large-scale, multicenter proteogenomic analysis offers new insights into pediatric brain tumor biology


A comprehensive “proteogenomic” analysis of the proteins, genes, and RNA transcription involved in pediatric brain tumors has yielded a more complete understanding of these tumors, which are the leading cause of cancer-related deaths in children. The results could help physicians more accurately identify different types of tumors and methods for treating them.

Researchers from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and Children’s Brain Tumor Network (CBTN) collected and analyzed what’s known as genetic, genomic, and proteomic data from multiple types of brain tumors in children. The consortia consist of collaborators from the Icahn School of Medicine at Mount Sinai, National Cancer Institute, Fred Hutchinson Cancer Research Center, Children’s National Hospital, and Children’s Hospital of Philadelphia. The study, the first large-scale multicenter study focused on pediatric brain tumors, was available online in Cell on November 25.

“Pediatric cancers in general, and pediatric brain tumors in particular, have a relatively low mutational burden,” explains Pei Wang, PhD, lead corresponding author of the study and Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. “Thus, comprehensive characterization of the functional molecular biology of these tumors, including the proteogenomic analysis done in this study, is essential to better understand and treat pediatric brain tumors.”

This study is the first comprehensive survey of genomics (which aims to characterize DNA sequence alterations in a sample), transcriptomics (which aims to quantify copies of RNAs), global proteomics (which aims to identify and quantify proteins), and phosphoproteomics (which quantifies active proteins) across a large cohort of 218 tumor samples representing seven distinct types of brain tumors.

By characterizing biological themes that are shared among these different types of tumors, the study revealed new insights suggesting that current treatments being used for specific tumor types could be applied to others that share the same proteomic features. Specifically, the analyses revealed two distinct subgroups of pediatric craniopharyngioma, a type of pediatric brain tumor. One subgroup showed proteomic/phosphoproteomic characteristics that were strikingly similar to those of another type of tumor, known as “low-grade glioma (LGG) with BRAFV600E mutation.” This observation suggests that MEK/MAPK inhibitors, a type of chemotherapy that has been used against LGG-with-BRAFV600E-mutation tumors, might also help with this subset of pediatric craniopharyngiomas, which currently has no robust chemotherapeutic options.

“The driver of this joint study has been a commitment to data-sharing and open science. Coming together has given both CPTAC and CBTN an opportunity to expand our available resources for answering critically important biological questions. Harnessing the collective expertise across these consortia enables us to better understand the mechanisms of pediatric tumors, improve the process of target protein identification, and potentially improve cancer treatments,” said Adam Resnick, PhD, contributing researcher, Scientific Co-Chair for CBTN, and Director of the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia.

By leveraging the rich clinical outcome data of this cohort, the research team also identified new prognostic biomarkers for a type of tumor known as high-grade glioma (HGG). When HGG tumors have a genetic mutation known as a H3K27M mutation, they tend to be very aggressive and the patients have relatively short survival time. However, in those without the mutation, this study suggests that the abundance of proteins named IDH1 and IDH2 in the tumor tissues could help to identify which tumors with the non-mutated H3K27M gene may be less aggressive.

“Integration of the clinical, proteomic, and genetic data generated in this study allows us to construct a more comprehensive model of brain tumor biology, which will lead to more targeted treatments,” said Brian Rood, MD, contributing researcher, Executive Co-Chair for CBTN, and Medical Director of the Brain Tumor Institute at Children’s National Hospital.

The data analysis also showed key biological differences in samples from primary and recurrent tumors from the same patients, indicating the need for independent assessment and therapeutic decisions for these tumors.

“The current study is the first to reveal in pediatric brain tumors the power of proteins to better determine which patient might benefit from a given therapy, and our validation studies using targeted proteomics provide a platform for clinical implementation of the findings” said co-author Amanda Paulovich, MD, PhD, Aven Foundation Endowed Chair and professor in the Clinical Research Division at Fred Hutchinson Cancer Research Center. “As this work moves further along toward clinical validation, I hope it brings comfort to patients and their families who have suffered from this terrible disease.”

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Maximizing Biorepositories for Research & Drug Discovery, New UpComing Webinar Hosted by Xtalks


biobanks face a variety of challenges in meeting the different interests and unique needs of their collaborators and partners in order to support a growing number of research studies

Genuity Science is bringing together a distinguished panel of experts from academia, research and industry to discuss opportunities and challenges facing biorepositories and biobanks around the world seeking to maximize their resources for research and drug discovery. Whether the repository contains a small collection of samples or is a large-scale national or international repository, biobanking will continue to play a key role in accelerating the discovery and development of new drugs, as these efforts require access to a larger array of biological samples. At the same time, biobanks face a variety of challenges in meeting the different interests and unique needs of their collaborators and partners in order to support a growing number of research studies. Maximizing utility and sustainability are critical for the long-term success of biorepositories and biobanks.

This webinar will explore the enormous innovative potential for biobanks and biorepositories to support translational research using a variety of bio-sample types (tissue samples, tumor cells, DNA, RNA, blood samples) collected from population-based and/or disease-specific groups of individuals.

Join Professor Stephen Sawcer, University of Cambridge, Dept. of Clinical Neurosciences; Samantha Hutten, Staff Scientist, Michael J Fox Foundation for Parkinson’s Disease Research (MJFF); Gordon R. Bernard, MD, Executive Vice President for Research and Chief Research Officer, Vanderbilt University Medical Center (VUMC); Professor Maeve Lowery, Trinity College Dublin and Consultant Medical Oncologist, St. James Hospital; and and David Kavanagh, PhD, Director of Clinical Partnerships, Genuity Science in a live webinar on Tuesday, December 15, 2020 at 10am EST (3pm GMT/UK).

For more information, or to register for this event, visit Maximizing Biorepositories for Research & Drug Discovery.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Sydney Perelmutter

Tel: +1 (416) 977-6555 x 352

Email: sperelmutter@xtalks.com

Share article on social media or email:

Is this the end of toothpaste as we know it?


miBrite ChewPaste - Natural Toothpaste Tablets

miBrite ChewPaste – Natural Toothpaste Tablets

“ChewPaste is by far the best toothpaste tablet available. It’s important that the tablets be completely non-toxic and safe to eat, so they are made with medical-grade hydroxyapatite for remineralization instead of fluoride,” says Dr. Martin Giniger, Ph.D, DMD

For the second week in a row, miBrite, the brand that sparks confidence and smiles, smashes all records and announces another paradigm-shifting platform toothpaste tablet technology: ChewPaste. The first in a series of tablets features an all-natural toothpaste, good for the environment, and uses medical-grade hydroxyapatite to remineralize teeth.

Toothpaste tablets have become popular recently due to the environmental benefits that tablets provide over traditional toothpaste. Regular toothpaste contains over 80% of its weight in humectants and water. The humectants added to toothpaste such as glycerin, sorbitol, and propylene glycol are added to toothpaste to prevent the toothpaste from drying up and becoming crumbling sand (silica).

In addition to these liquids added into toothpaste that increases the weight and volume, liquids make it challenging to add many beneficial ingredients to the formulation since water will eventually break down the ingredient’s structure and make the ingredient no longer effective.

miBrite ChewPaste has been in development for years and is the innovation of the world’s top oral care researcher and product formulator, Dr. Martin Giniger, Ph.D., DMD. Dr. Giniger has a Ph.D. in biochemistry and has worked with many large pharmaceutical companies on developing new drugs. This experience has guided the development of miBrite ChewPaste to result in a soft-to-chew tablet which can deliver beneficial ingredients.

“We spent a great deal of time on the formulation of miBrite ChewPaste so that it would provide a better experience than traditional toothpaste and not only be a more environmentally conscious alternative,” says Dr. Giniger, adding, “ChewPaste is by far the best toothpaste tablet available. It’s important that the tablets be completely non-toxic and safe to eat, so they are made with medical-grade hydroxyapatite for remineralization instead of fluoride.”

Besides not containing any added liquids to miBrite ChewPaste, they are also sold in recycled and recyclable and reusable metal tins and use recycled paper for the outside box. miBrite ChewPaste is available in two different sizes: a 30 day supply (60 ChewPaste tablets) and a 90 day supply (180 tablets).

For more information, visit miBrite’s website: http://www.mibrite.com

About Smash Labs, LLC and miBrite

Smash Labs, LLC is a multi-faceted oral care product innovation international firm based in Boca Raton, Florida, and Amsterdam, The Netherlands. Dr. Martin Giniger, Ph.D., DMD heads the company as Smash Lab’s Chief Scientist and works together with Oral Care R&D formulator Matt Spaid. Smash Labs works closely with companies worldwide and helps them formulate the products of their dreams. For more information, visit http://www.smash-labs.com and http://www.mibrite.com

###

Share article on social media or email: